Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.

Otsuka

Status: Enrolling

Conditions: Heart Failure

Treatments: Drug: Samtasu for I.V. infusion

Study type: Observational

Funder types: Industry

Identifiers

NCT05712746

263-101-00017

Details and patient eligibility

About

To confirm the safety of tolvaptan sodium phosphate in patients with volume overload in heart failure.

Enrollment: 1,600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria

• patients with a known hypersensitivity to Tolvaptan sodium phosphate or Tolvaptan